Upregulation of drug sensitivity of multidrug-resistant SGC7901/VCR human gastric cancer cells by bax gene transduction

Chinese Medical Journal

Volumn 113, Issue 11, 2000, Pages 977-980

  Zhao, Yanqiu ^a   Xiao, Bing ^b   Chen, Baojun ^a   Qiao, Taidong ^a   Fan, Daiming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FIRST MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Bax; Gastric cancer; Gene transduction; Multidrug resistance

Indexed keywords

ANTINEOPLASTIC AGENT; BAX PROTEIN, HUMAN; DOXORUBICIN; ONCOPROTEIN; PROTEIN BAX; PROTEIN BCL 2; VINCRISTINE;

ARTICLE; CELL CULTURE; DRUG RESISTANCE; GENETIC TRANSDUCTION; GENETICS; HUMAN; MULTIDRUG RESISTANCE; PATHOLOGY; STOMACH TUMOR; UPREGULATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BCL-2-ASSOCIATED X PROTEIN; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; STOMACH NEOPLASMS; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED; UP-REGULATION; VINCRISTINE;

EID: 0034334089     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Dole MG, Jasty R, Cooper MJ, et al. Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis. Cancer Res 1995;55:2576-2282.
2. Minn AJ, Rudin CM, Boise LH, et al. Expression of bcl-xL can confer a multidrug resistance phenotype. Blood 1995;86:1903-1910.
3. Kaufmann SH, Karp JE, Svingen PA. Elevated expression of the apoptosis regulator Mcl-1 at the time of leukemic relapse. Blood 1998;91:991-1000.
4. Sumantran VN, Ealovega MW, Nunez G, et al. Overexpression of Bcl-xs sensitizes MCF-7 cells to chemotherapy-induced apoptosis. Cancer Res 1995;55:2507-2510.
5. Wagener C, Bargou RC, Naniel PT, et al. Induction of the death-promoting gene Bax-α sensitizes cultured breast-cancer cells to drug-induced apoptosis. Int J Cancer 1996;67:138-141.
6. Cai XJ, Fan DM, Zhang XY. Establishment and biological characteristics of multidrug resistant gastric cancer cell line. J Chin Clin Cancer 1994;9:56-63.
7. Oltvai ZN, Milliman CL, Korsmeyer SL. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609-619.
8. Sarbia M, Bittinger F, Grabellus F, et al. Expression of Bax, a pro-apoptosis member of the Bcl-2 family in esophageal squamous cell carcinoma. Int J Cancer 1997;73:508-513.
9. Perego P, Giarola M, Righetti SC, et al. Association between cisplatin resistance and mutation of p53 gene and reduced Bax expression in ovarian carcinoma cell systems. Cancer Res 1996;56: 556-562.
10. Yanase N, Takada E, Yoshihama I, et al. Participation of Bax-alpha in IFN-alpha-mediated apoptosis in Daudi B lymphoma cells. J Interferon Cytokine Res 1998;18:855-861.
11. Gutierrez MI, Cherney B, Hussain A, et al. Bax is frequently compromised in Burkitt s lymphomas with irreversible resistance to Fas-induced apoptosis. Cancer Res 1999;59:696-703.
12. Finucane DM, Bossy WE, Waterhouse NJ, et al. Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL. J Biol Chem 1999;274:2225-2233.
13. Gomez G, Berns A, Brady HJ. A link between cell cycle and cell death: Bax and Bcl-2 modulate Cdk2 activation during thymocyte apoptosis. EMBO J 1998;17:7209-7218.
14. Strasser A, Huang DC, Vaux DL. The role of the bcl-2/ced-9 gene family in cancer and general implications of defects in cell death control for tumourigenesis and resistance to chemotherapy. Biochim Biophys Acta 1997;1333:F151-F178.